Fortescue Ltd (FSUGY)

Revance Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	35,673	43,940	45,408	37,160	53,850	29,430
Market Cap Growth	-42.91%	-3.23%	22.19%	-30.99%	82.97%	51.21%
Enterprise Value	37,762	44,526	47,444	38,802	53,977	30,150
Last Close Price	23.07	26.33	24.94	18.27	22.87	11.18
PE Ratio	9.15	7.73	9.46	6.00	5.23	6.22
PS Ratio	2.18	2.41	2.69	2.14	2.42	2.30
PB Ratio	1.86	2.25	2.52	2.14	3.04	2.22
P/TBV Ratio	1.89	2.29	2.57	2.18	3.04	2.23
P/FCF Ratio	10.73	8.64	10.02	9.67	5.85	6.58
P/OCF Ratio	5.77	5.55	6.11	5.59	4.28	4.59
EV/Sales Ratio	2.22	2.44	2.81	2.23	2.42	2.35
EV/EBITDA Ratio	4.34	4.24	4.95	3.70	3.31	3.71
EV/EBIT Ratio	6.12	5.23	5.92	4.26	3.58	4.40
EV/FCF Ratio	11.36	8.76	10.47	10.10	5.86	6.75
Debt / Equity Ratio	0.28	0.28	0.30	0.35	0.24	0.39
Debt / EBITDA Ratio	0.65	0.51	0.55	0.57	0.26	0.62
Debt / FCF Ratio	1.64	1.06	1.17	1.59	0.46	1.14
Asset Turnover	0.55	0.63	0.60	0.61	0.86	0.60
Inventory Turnover	6.25	6.39	6.88	6.66	6.66	7.18
Quick Ratio	1.89	2.07	1.95	2.36	1.97	1.93
Current Ratio	2.70	2.67	2.47	2.85	2.31	2.25
Return on Equity (ROE)	20.09%	30.19%	27.14%	35.33%	66.46%	39.72%
Return on Assets (ROA)	12.56%	18.27%	17.69%	20.05%	36.42%	19.88%
Return on Capital (ROIC)	15.04%	22.07%	21.41%	25.04%	46.75%	26.03%
Return on Capital Employed (ROCE)	22.00%	31.10%	31.10%	35.10%	61.60%	33.30%
Earnings Yield	10.93%	12.93%	10.57%	16.68%	19.12%	16.09%
FCF Yield	9.32%	11.57%	9.98%	10.34%	17.11%	15.19%
Dividend Yield	7.81%	4.99%	4.67%	7.81%	11.74%	10.87%
Payout Ratio	103.98%	72.85%	81.74%	108.10%	55.21%	40.66%
Buyback Yield / Dilution	-0.01%	0.02%	0.04%	0.18%	0.05%	0.28%
Total Shareholder Return	7.80%	5.01%	4.71%	7.98%	11.79%	11.15%

Updated Feb 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.